Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Non-Current Deferred Tax Liability (2016 - 2018)

Historic Non-Current Deferred Tax Liability for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $1.1 million.

  • Armata Pharmaceuticals' Non-Current Deferred Tax Liability changed 0.0% to $1.1 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.1 million for FY2017, which is 5316.46% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Non-Current Deferred Tax Liability of $1.1 million as of Q3 2018, which was down 0.0% from $1.1 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Non-Current Deferred Tax Liability's 5-year high stood at $3.1 million during Q1 2014, with a 5-year trough of $1.1 million in Q2 2017.
  • In the last 5 years, Armata Pharmaceuticals' Non-Current Deferred Tax Liability had a median value of $3.0 million in 2015 and averaged $2.4 million.
  • In the last 5 years, Armata Pharmaceuticals' Non-Current Deferred Tax Liability changed by 0.0% in 2014 and then tumbled by 6183.03% in 2017.
  • Armata Pharmaceuticals' Non-Current Deferred Tax Liability (Quarter) stood at $3.1 million in 2014, then dropped by 2.37% to $3.0 million in 2015, then fell by 18.5% to $2.4 million in 2016, then crashed by 53.16% to $1.1 million in 2017, then changed by 0.0% to $1.1 million in 2018.
  • Its last three reported values are $1.1 million in Q3 2018, $1.1 million for Q2 2018, and $1.1 million during Q1 2018.